Skip to main content
Clinical Trials/CTRI/2021/12/038553
CTRI/2021/12/038553
Not yet recruiting
未知

â??Evaluation of efficacy of Presepsin as a sepsis biomarker in Neonatal Sepsis-A pilot studyâ??

AIIMS Raipur0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
AIIMS Raipur
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
AIIMS Raipur

Eligibility Criteria

Inclusion Criteria

  • ï?ª All Neonates admitted in Neonatal unit with clinical suspicion of sepsis for
  • whom either workup for sepsis or blood culture will be sent before initiation
  • of antibiotics.
  • ï?ª Diagnosis of sepsis would be based on presence of clinical findings (one or
  • more than one clinical finding) which would include the following 1\. Respiratory compromise: respiratory rate \>60 breaths per minute, or
  • cessation of respiration for \>\=20 seconds, occurring at a rate of \>\=2
  • times per hour, or pulse oxymeter readings of \<\=90%
  • 2\. Cardiovascular compromise: heart rate \<100 beats per minute or
  • more than 180/min with other physiological causes ruled out,
  • pallor,or hypotension.

Exclusion Criteria

  • Neonates who had recently undergone surgical interventions.
  • ï?· Patients who had confirmed intrauterine infection (toxoplasmosis, rubella,
  • cytomegalovirus, syphilis, and herpes).
  • ï?· Babies having major malformations and inborn error of metabolism (IEM).
  • ï?· Patients for whom consent cannot be taken from the parents.

Outcomes

Primary Outcomes

Not specified

Similar Trials